<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        28-171-99
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NORACIN 400MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        NORFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        400
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        22.2
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1055]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Dallah Health Care Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01MA06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><br />NORACIN contains a medicine called Norfloxacin. This is an antibiotic which works against a large number of bacteria.<br />NORACIN is used for infections of the urinary system. It works by killing bacteria that can cause infections of your urinary<br />system.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take NORACIN if:<br />□ You are allergic (hypersensitive) to Norfloxacin or any of the other ingredients of NORACIN (listed in Section 6)<br />□ You are pregnant or think you could be pregnant (see &lsquo;Pregnancy and breastfeeding&rsquo; section below)<br />□ You have had a reaction to a similar medicine in the past<br />□ The patient is a child or young person who is still growing.<br />Do not take NORACIN if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking<br />NORACIN.<br />Take special care with NORACIN:<br />Check with your doctor or pharmacist before taking your medicine if:<br />□ You have ever had fits (convulsions)<br />□ You have ever had an illness that causes fits, such as epilepsy<br />□ You have an illness called myasthenia gravis which causes muscle weakness<br />□ You or anyone in your family has anaemia caused by an illness called glucose-6-phosphate dehydrogenase deficiency<br />(also called G-6-PD deficiency)<br />□ You or anyone in your family have ever had any problems with uneven heart beats (arrhythmias). This might include<br />something called prolonged QT interval.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking NORACIN.<br />Peripheral neuropathy:<br />Peripheral neuropathies have been associated with NORACIN use that symptoms may occur soon after initiation of therapy<br />and may be irreversible. If symptoms of peripheral neuropathy including pain, burning, tingling, numbness and/or weakness<br />develop, patients should immediately discontinue NORACIN and contact their physician.<br />Diarrhoea:<br />Diarrhoea is a common problem caused by antibiotics, which usually ends when the antibiotic is discontinued. Sometimes<br />after starting the treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps<br />and fever) even as late as two more months after having taken the last dose of the antibiotic. If this occurs, you should speak<br />to your doctor as soon as possible.<br />NORACIN and the sun:<br />Keep out of the sun as much as possible while taking NORACIN. This is because the medicine may cause an allergic<br />reaction in some patients when they go in the sun.<br />Taking other medicines, herbal or dietary supplements:<br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines<br />obtained without a prescription. This includes herbal medicines. This is because NORACIN can affect the way some other<br />medicines work. Also some other medicines can affect the way NORACIN works.<br />Some medicines can reduce the amount of NORACIN that gets into the body. Leave a gap of at least two hours after taking<br />NORACIN before taking any of these medicines:<br />□ Antacids - used for indigestion or heartburn<br />□ Sucralfate - used for stomach ulcers or an inflamed stomach (gastritis)<br />□ Didanosine - used for HIV or AIDS<br />□ Medicines containing iron or zinc including multivitamins and minerals.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking NORACIN.<br />It is also particularly important to tell your doctor or pharmacist if you take:<br />□ Theophylline - used for asthma and also found in some cough and cold medicines<br />□ Medicines used to thin the blood, such as warfarin<br />□ Fenbufen - used for joint pain<br />□ Non-steroidal anti-inflammatory drugs ( NSAIDS)- used for pain and other illnesses<br />□ Ciclosporin - used after transplants and for some other illnesses<br />□ Probenecid - used for gout and arthritis caused by gout<br />□ Nitrofurantoin - used for water-works infection<br />□ Caffeine - found in some cough and cold medicines and also in some drinks for example tea, coffee and cola drinks<br />□ Clozapine - used to treat schizophrenia<br />□ Ropinirole - used to treat Parkinson&#39;s disease<br />□ Tizanadine - used to treat muscle spasms</p><p>□ Glibenclamide - used for diabetes<br />□ Cisapride - used for indigestion, heartburn, feeling sick or being sick<br />□ Erythromycin - an antibiotic<br />□ Medicines used for mental illness called neuroleptics ( such as phenothiazine or antipsychotics<br />□ Medicines used for depression called tricyclic antidepressants, such as amitriptyline, clomipramine, imipramine and<br />nortriptyline<br />□ Medicines used for uneven heart beats (arrhythmias), such as quinidine, procainamide, sotalol and amiodarone<br />□ Medicines used for lots of types of illness called corticosteroids, such as prednisolone, dexamethasone and hydrocortisone.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking NORACIN.<br />Taking NORACIN with food and drink:<br />Take NORACIN with a glass of water. Take NORACIN at least one hour before or two hours after food or milk.<br />Pregnancy and breastfeeding:<br />Pregnancy:<br />Do not take NORACIN if you are pregnant or think you might become pregnant. This is because it may affect the baby.<br />Breast-feeding:<br />Do not breast-feed if you are taking NORACIN. This is because small amounts may pass into the mother&rsquo;s milk.<br />Ask your doctor for advice before taking any medicine, if you are pregnant or breast- feeding.<br />Driving and using machines:<br />You may feel dizzy while taking NORACIN. If this happens do not drive or use any tools or machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take NORACIN exactly as your doctor told you. You should check with your doctor or pharmacist if you are not sure.<br />REMEMBER, this medicine is for you. Do not share it with anyone else. It may not suit them.<br />Taking this medicine:<br />□ Take at least one hour before or two hours after food or milk<br />□ Swallow the tablets whole with a full glass of water.<br />How much to take:<br />The dose depends on your illness and how bad it is. The usual dose is:<br />□ For less serious infections - one tablet twice a day for 3 days<br />□ For more serious infection - one tablet twice a day for 7 to 10 days<br />If the infection comes back, your treatment can be for up to 12 weeks.<br />If you take more NORACIN than you should:<br />If you take more NORACIN than you should, talk to your doctor straight away.<br />If you forget to take NORACIN:<br />□ If you forget to take a tablet, skip the missed dose.<br />□ Take the next dose as usual.<br />□ Do not take a double dose to make up for a forgotten dose.<br />If you stop taking NORACIN:<br />Keep taking these tablets until the course is finished. Keep taking them, even if you start to feel better after a few days.<br />If you have any further questions on the use of this product, ask your doctor or pharmacist</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines NORACIN can cause side effects, although not everybody gets them.<br />The following side effects may happen with this medicine:<br />Stop taking and tell your doctor straight away if you notice any of the following serious side effects, you may need<br />urgent medical treatment.<br />□ Allergic reaction &ndash; the signs may include swelling of your face, lips, tongue and throat. This may make it difficult to breathe<br />or swallow.<br />□ Skin rashes with itching and lumps under the skin (nettle rash).<br />Other side effects include:<br />Heart and circulation<br />□ Uneven heart beats (arrhythmias)<br />□ Changes in blood flow to some parts of your body, such as the skin, head or leg caused by inflammation of the blood<br />vessels (vasculitis).<br />Skin and hair<br />□ A serious skin reaction that causes blisters and bleeding called &lsquo;Stevens-Johnson&rsquo;<br />syndrome<br />□ Dermatitis<br />□ Skin reactions to sunlight<br />Nervous system<br />□ Headache<br />□ Dizziness<br />□ Pins and needles<br />□ Diminished sensibility<br />□ Partial loss of sensation<br />□ Fits (convulsions)<br />□ Shaking movements (tremors)<br />□ Confusion<br />□ An illness called &lsquo;Gullain-Barr&eacute;&rsquo; syndrome. This makes you weak and can make it difficult to breath.<br />Eyes or ears<br />□ Ringing in the ears<br />□ Hearing loss<br />□ Overflow of tears<br />□ Changes in your eyesight</p><p>Infections<br />□ Thrush (vaginal)<br />Stomach and gut<br />□ Changes in taste<br />□ Sickness, stomach cramps, indigestion or diarrhoea<br />□ Loss of appetite<br />□ Severe pain in your guts, high temperature, fever, diarrhoea (which may contain<br />blood), vomiting and yellow colour to skin (all caused by inflammation of the colon, liver or pancreas)<br />Blood<br />□ Low white blood cells which may cause frequent infections, fever, severe chills, sore throat or mouth<br />□ Increased white blood cells<br />□ Bleed for a long time after a cut or bruise very easily<br />□ Changes in blood tests that check for liver problems<br />□ Being pale and tired. This may be due to anaemia especially in patients with something called &lsquo;glucose-6-phosphate<br />dehydrogenase deficiency&rsquo; due to a red cell loss.<br />Joints and muscles<br />□ Making worse the illness called &lsquo;myasthenia gravis&rsquo; (this illness causes muscle weakness).<br />□ Inflammation of the tendons, tendon rupture<br />□ Swelling of joints causing pain and stiffness<br />□ Swelling of the muscles causing aches or pains<br />□ Pain and swelling of tendons, often around your ankles. This is more common if you are an older person, or are taking<br />steroid medicines such as prednisolone, dexamethasone or hydrocortisone. Try to rest the painful areas until a doctor is<br />seen.<br />□ Involuntary muscle twitches<br />Urinary<br />□ Poor or no kidney function<br />□ High temperature or pain in your lower back or side. This may be due to inflammation of the kidneys.<br />□ Pain on passing urine<br />Mental illness<br />□ Not sleeping very well<br />□ Depression<br />□ Feeling nervous (anxiety)<br />□ Feeling restless (irritability)<br />□ Loss of contact with reality (psychosis)<br />□ Feeling disorientated<br />□ Seeing things that are not really there (hallucination)<br />□ Feeling confused<br />If any of these side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or<br />pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />□ Do not store above 30&deg;C, protected from light and humidity.<br />□ Do not use NORACIN after the expiry date which is stated on the carton and on the blister, after (EXP).Date.<br />Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines<br />no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What NORACIN contains:<br />□ The active substance is Norfloxacin. Each Film Coated Tablet contains 400 mg of Norfloxacin.<br />□ The other ingredients are: stearic acid, sodium starch glycollate, microcrystalline cellulose, povidone K 29-32, sodium lauryl<br />sulphate, colloidal anhydrous silica, opadry OY-8413</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What NORACIN looks like and contents of the pack:
□ NORACIN Tablets are mustard, oval biconvex film coated tablets, plain on both sides.
□ Boxes of 14 blistered tablets of NORACIN 400.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Jordanian pharmaceutical manufacturing co.(P.L.C.|)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                in: January 2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><br />يحتوي نوراسين على المادة الفعالة نورفلوكساسين. وهو عبارة عن مضاد حيوي له تأثير مضاد لعدد كبير من البكتيريا.<br />يستخدم نوراسين لمعالجة عدوى الجهاز البولي. وهو يعمل على قتل البكتيريا التي تسبب العدوي للجهاز البولي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />موانع استعمال نوراسين:<br />( إذا كنت تعاني من الحساسية (فرط التحسس) لنورفلوكساسين أو أي من مكونات نوراسين الأخرى (المدرجة في قسم ٦ □<br />إذا كنت حاملأ أو تعتقدي بانك حاملاً (انظر قسم الحمل والرضاعة أدناه) □<br />إذا كنت تعاني مسبقأ من أي تفاعل لدواء يشبه هذا الدواء □<br />إذا كنت طفلاً أو شاباً صغير في السن. □</p><p>لا تتناول نوراسين إذا كان أياً من المذكور أعلاه ينطبق عليك. استشر الطبيب أو الصيدلي في حال كنت غير متأكد.</p><p>المذكور أعلاه ينطبق عليك. استشر الطبيب أو الصيدلي في حال كنت غير متأكد.<br />الاحتياطات عند استعمال نوراسين:<br />استشر الطبيب أو الصيدلي قبل تناول هذا الدواء إذا:<br />كنت تعاني من تشنجات. □<br />كنت تعاني من مرض يسبب لك نوبات مثل الصرع. □<br />كنت تعاني من مرض يسمى الوهن العضلي الوبيل والذي يسبب ضعف العضلات. □<br />كنت تعاني أنت أو أي شخص في عائلتك من فقر الدم الناجم عن مرض يدعى عوز نازعة هيدروجين الغلوكوز- ٦- فسفات. □<br />في تخطيط كهربية القلب. QT كنت تعاني أنت أو أي شخص في عائلتك من مشاكل عدم انتظام ضربات القلب، وهذا قد يشمل ما يسمى بإطالة فترة □<br />استشر الطبيب أو الصيدلي قبل تناول نوراسين إذا لم تكن متأكداً إذا كان أياً من أعلاه ينطبق عليك.<br />اعتلال الأعصاب المحيطية:<br />ارتبط حدوث اعتلال الأعصاب المحيطية باستخدام نوراسين وقد تحدث الأعراض بعد فترة وجيزة من بدء العلاج وقد تكون لا رجعة فيها. يجب وقف استخدام<br />نوراسين مباشرة واستشارة الطبيب إذا تفاقمت أعراض الاعتلال العصبي التي تشتمل على آلام و/أو حرق و/أو وخز و/أو خدر و/أو ضعف.<br />الإسهال:<br />يعتبر الإسهال من المشاكل الشائعة الناتجة عن استخدام المضادات الحيوية، والتي عادةً ما تنتهي عند وقف استخدام المضاد الحيوي. بعد بدء المعالجة باستخدام<br />المضادات الحيوية قد يصاب المريض في بعض الأحيان ببراز مائي ودموي (مع أو بدون تقلصات في المعدة و حمى) و قد يحدث ذلك في وقت متأخر بعد أكثر من<br />شهرين من تناول أخر جرعة من المضاد الحيوي. إذا حدث ذلك، فإن عليك استشارة الطبيب في أسرع وقت ممكن.<br />استخدام نوراسين في الشمس:<br />يجب الابتعادعن أشعة الشمس قدر الإمكان عند استخدام نوراسين، لأن هذا الدواء قد يسبب تفاعلات تحسسية لدى بعض المرضى عند تعرضهم لأشعة الشمس.<br />التداخلات الدوائية من أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية:<br />يرجى إخبار طبيبك أو الصيدلي إذا تناولت مؤخراً أي أدوية أخرى، بما في ذلك، الأدوية التي تم الحصول عليها دون وصفة طبية، وهذا يشمل الأدوية العشبية.<br />وذلك لأن نوراسين قد يؤثرعلى آلية عمل الأدوية الأخرى وكذلك قد تؤثر الأدوية الأخرى على آلية عمل نوراسين.<br />قد تقلل بعض الأدوية من كمية نوراسين داخل الجسم. يجب ترك ساعتين على الأقل بعد تناول نوراسين وقبل تناول أياً من الأدوية التالية:<br />مضادات الحموضة: تستخدم لمعالجة عسر الهضم و حرقة الفؤاد □<br />سكرالفيت: يستخدم لمعالجة قرحة المعدة أو التهاب المعدة □<br />ديدانوزين: يستخدم لمعالجة مرض الإيدز □<br />الأدوية التي تحتوي على حديد أو زنك والتي تشمل الفيتامينات المتعددة و المعادن. □<br />استشر الطبيب أو الصيدلي قبل تناول نوراسين إذا لم تكن متأكداً مما إذا كان أي من أعلاه ينطبق عليك.<br />كما أنه من الأهمية القصوى أن تخبر الطبيب أو الصيدلي إذا كنت تتناول:<br />الثيوفيلين: يستخدم لمعالجة الربو، وهو موجود في بعض أدوية السعال والبرد □<br />الأدوية التي تستخدم لتمييع الدم، مثل الوارفارين □<br />فينبوفين: يستخدم لمعالجة ألم المفاصل □<br />الأدوية المضادة للالتهاب غير الستيرويدية: تستخدم لمعالجة الألم والأمراض الأخرى □<br />سايكلوسبورين: يستخدم بعد عملية الزرع ويعالج بعض الأمراض الأخرى □<br />بروبنيسيد: يستخدم لمعالجة النقرص والتهاب المفاصل الناجم عن النقرص □<br />نتروفورانتوين: تستخدم لمعالجة عدوى المسالك البولية □<br />كافايين: موجود في بعض ادوية السعال والبرد وأيضاً في بعض المشروبات مثل الشاي والقهوة والمشروبات الغازية □<br />كلوزابين: يستخدم لمعالجة مرض الفصام □<br />روبنيرول: يستخدم لمعالجة مرض الباركنسون □<br />تيزانيدين: يستخدم لمعالجة التشنجات العضلية □<br />غليبنكلامايد: يستخدم لمعالجة مرض السكري □<br />سيسابرايد: يستخدم لمعالجة عسر الهضم، حرقة الفؤاد، الغثيان أو القيء □<br />إيريثرومايسن: مضاد حيوي □<br />الأدوية التي تستخدم لمعالجة الأمراض العقلية التي تسمى الذهان (مثل فينوثيازين أو مضادات الذهان) □<br />الأدوية التي تستخدم لمعالجة الاكتئاب والتي تسمى مضادات الاكتئاب ثلاثية الحلقات مثل، أميتريبتيلين، كلوميبرامين، إيميبرامين ونورتريبتيلين</p><p>الأدوية التي تستخدم لمعالجة عدم انتظام ضربات القلب مثل، كينيدين، بروكايينامايد، وسوتالول و أميودارون □<br />الأدوية المستخدمة لمعالجة العديد من الأمراض والتي تسمى الكورتيكوستيرويدات مثل، بريدنيزولون، ديكساميثازون والهيدروكورتيزون. □<br />استشر الطبيب أو الصيدلي قبل تناول نوراسين إذا لم تكن متأكداً إذا كان أياً من أعلاه ينطبق عليك.<br />تناول نوراسين مع الطعام والشراب:<br />تناول نوراسين مع كوب من الماء، وقبل ساعة على الأقل أو بعد ساعتين من تناول الطعام أو الحليب.<br />الحمل والرضاعة:<br />الحمل:<br />لا تتناولي نوراسين إذا كنت حاملاً أو تعتقدي بأنك حامل، لأنه قد يؤثر على الطفل.<br />الرضاعة:<br />لا ينصح بالإرضاع أثناء تناول نوراسين، لأنه قد تتنقل كميات قليلة منه في حليب الأم.<br />اسألي الطبيب أو الصيدلي للحصول على المشورة قبل تناول أي دواء إذا كنت حامل أو مرضعة.<br />تأثير المستحضر على القيادة واستخدام الآلات:<br />قد تشعربالدوار أثناء تناول نوراسين. يجب أن لا تقود السيارة أو تستخدم أي أداة أو آلة إذا شعرت بذلك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />يجب أن تتناول نوراسين بالضبط كما أخبرك الطبيب. يجب عليك مراجعة الطبيب أو الصيدلي إذا كنت غير متأكد.<br />تذكر بأن هذا الدواء لك، فلا تتشارك به مع أي شخص آخر لأنه قد لا يتناسب معه.<br />طريقة تناول الدواء:<br />تناول هذاء الدواء قبل ساعة على الأقل أو بعد ساعتين من تناول الطعام أو الحليب. □<br />ابتلع القرص مع كوب كامل من الماء. □<br />مقدار الجرعة:<br />تعتمد الجرعة على مدى تفاقم حالتك المرضية، و الجرعة الاعتيادية هي:<br />العدوى الأقل خطورة: قرص واحد مرتين يومياً ولمدة ثلاثة أيام. □<br />العدوى الأكثر خطورة: قرص واحد مرتين يومياً ولمدة تتراوح ما بين ۷ إلى ۱۰ أيام. □<br />إذا رجعت العدوى مرة أخرى، فإن العلاج يجب أن يستمر لمدة ۱۲ أسبوع.<br />الجرعة الزائدة من نوراسين:<br />إذا تناولت جرعة أكثر مما يجب، فإن عليك التحدث لطبيبك مباشرة.<br />نسيان تناول جرعة نوراسين:<br />تخطى الجرعة المنسية في حال أنك نسيت تناولها. □<br />تناول الجرعة التالية كما هو معتاد. □<br />لا تضاعف الجرعة لتعويض الجرعة المنسية. □<br />التوقف عن تناول نوراسين:<br />يجب أن تستمر في تناول أقراص الدواء حتى ينتهي المقرر العلاجي، وأيضاً يجب أن تستمر في تناولها حتى لو شعرت بتحسن بعد بضعة أيام من العلاج.<br />اسأل الطبيب أو الصيدلي إذا كان لديك أي أسئلة أخرى حول استعمال هذا المستحضر</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، فإن نوراسين قد يسبب آعراضاً جانبية، بالرغم من أنها لاتحدث للجميع.<br />الأعراض الجانبية التالية قد تحدث عند استخدام هذا الدواء:<br />توقف عن تناول الدواء وأخبر طبيبك على الفور إذا لاحظت أي من الأعراض الجانبية الخطيرة التالية، فقد تحتاج إلى معالجة طبية عاجلة:<br />تفاعل تحسسي: وقد يشمل علامات تورم في الوجه والشفاه واللسان والحلق، وهذا قد يؤدي إلى صعوبة في التنفس أو البلع. □<br />طفح جلدي مع حكة وكتل تحت الجلد (طفح القراص). □<br />الأعراض الجانبية الأخرى:<br />القلب والدورة الدموية:<br />عدم انتظام ضربات القلب □<br />التغيرات في تدفق الدم لبعض أجزاء الجسم مثل الجلد أو الرأس أو القدم الذي يسببه التهاب الأوعية الدموية. □<br />الجلد والشعر:<br />تفاعل جلدي خطير يتسبب بظهور بثور وحدوث نزف و يسمى بمتلازمة ستيفنز جونسون □<br />التهاب الجلد □<br />تفاعلات جلدية لأشعة الشمس. □<br />الجهاز العصبي:<br />صداع □<br />دوخة □<br />الاحساس بالوخز والخدر □<br />انخفاض الإحساس □<br />فقدان جزئي بالإحساس □<br />نوبات (تشنجات) □<br />رعشة □<br />ارتباك □<br />مرض يسمى بمتلازمة غيان باريه والذي يتسبب بضعف الجسم وصعوبة في التنفس. □<br />العينين أو الأذنين:<br />طنين الأذنين □<br />فقدان السمع □<br />تدفق الدمع □<br />تغيرات بصرية □<br />العدوى:<br />سلاق مهبلي □</p><p>المعدة والأمعاء:<br />تغيرات في الذوق □<br />غثيان، تقلصات في المعدة، عسر الهضم أو الإسهال □<br />فقدان الشهية □<br />ألم شديد في القناة الهضمية، ارتفاع درجة الحرارة، حمى، إسهال (وقد يحتوي على دم)، قيء واصفرار الجلد (وكلها ناتجة عن التهاب القولون أو الكبد أو □<br />البنكرياس).<br />الدم:<br />انخفاض عدد كريات الدم البيضاء والذي قد يؤدي إلى حدوث عدوى بشكل متكرر، حمى، قشعريرة شديدة، التهاب الحلق أو الفم □<br />زيادة عدد كريات الدم البيضاء □<br />نزف لفترة طويلة بعد حدوث جرح أو حدوث كدمات بكل سهولة □<br />تغيرات في فحوصات الدم للتحقق من مشاكل الكبد □<br />الشحوب والتعب الناتج عن فقر الدم وخاصة لدى المرضى الذين يعانون من عوز نازعة هيدروجين الغلوكوز- ٦- فسفات بسبب فقدان خلايا الدم الحمراء. □<br />المفاصل والعضلات:<br />الوهن العضلي الوبيل (هذا المرض يسبب ضعف في العضلات). □<br />التهاب الأوتار، تمزق الأوتار □<br />تورم المفاصل الذي يسبب الألم والتيبس □<br />تورم العضلات الذي يسبب الألم □<br />ألم وتورم الأوتار وعادةً ما يكون حول الكاحلين، وهذا يكون أكثر شيوعاً عندما يكون الشخص كبير في السن أو يتناول أدوية الستيرويد مثل بريدنيزولون، □<br />ديكساميثازون أو الهيدروكورتيزون. حاول بأن تريح المناطق المؤلمة حتى ينظر اليك الطبيب.<br />تشنجات عضلية غير إرادية □<br />الجهاز البولي:<br />ضعف أو قصور في وظيفة الكلى □<br />ارتفاع درجة الحرارة أو ألم في أسفل الظهر أو الجوانب الناجم عن التهابات الكلى □<br />ألم عند التبول. □<br />الأمراض العقلية:<br />عدم النوم بشكل جيد □<br />اكتئاب □<br />الشعور بالعصبية (القلق) □<br />الشعور بالتملل (التهيج) □<br />فقدان الاتصال بالواقع (الذهان) □<br />الشعور بالتوهان □<br />رؤية الأشياء غير الواقعية (هلوسة) □<br />الشعور بالارتباك □<br />إذا أصبحت أي من هذه الأعراض الجانبية خطيرة، أو إذا لاحظت أي أعراض جانبية غير المدرجة في هذه النشرة، يرجى إخبار طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />يحفظ بعيداً عن متناول الأطفال. □<br />لا يحفظ بدرجة حرارة أعلى من ۳۰ &deg;م، يحفظ بعيداً عن الضوء والرطوبة. □<br />لا ينبغي استعمال نوراسين بعد تاريخ انتهاء الصلاحية الموجود على العلبة وعلى شريط الدواء. □<br />لا ينبغي التخلص من الأدوية من خلال مياه الصرف الصحي أو المنزلي. اسأل الصيدلاني عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. سوف تساعد هذه<br />الاجراءات على حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />المادة الفعالة هي نورفلوكساسين. كل قرص مغلف يحتوي على ٤۰۰ ملغم من نورفلوكساسين. □<br />سلفات لوريل الصوديوم، سليكا غروية ،K ۳۲- المكونات الأخرى هي: حمض الستياريك، غليكولات نشا الصوديوم، سيلولوز بلوري مكروي، بوفيدون ۲۹ □<br />.OY- لامائية، أوبادراي ۸٤</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            
أقراص نوراسين هي أقراص مغلفة بيضوية الشكل لونها خردلي وملساء من كلا الجانبين . □
علب تحتوي على ۱٤ قرص من أقراص نوراسين ٤۰۰ المحفوظة في أشرطة
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة الاردنية لانتاج الادوية المساهمة العامة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            في: كانون الثاني2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                NORACIN 400 film coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active ingredient:

 Norfloxacin 400 mg.







Inactive ingredients:

Ingredient	Quantity
mg/tab.
Stearic Acid 	16.0
Sodium Starch Glycollate 	89.0
Microcrystalline Cellulose 	20.0
Povidone K 29-32	10.0
Sodium Lauryl Sulphate	10.0
Colloidal Anhydrous Silica	15.0
Opadry OY-8413	15.0

      *For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Mustard, oval biconvex film coated tablet, with plain on both sides.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Norfloxacin is a broad-spectrum, quinolone bactericidal agent indicated for the treatment of:</p><p>&nbsp;</p><p>q&nbsp; Uncomplicated urinary tract infections (including cystitis) due to Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus epidermidis,Staphylococcus saprophyticus, Citrobacter freundii1, Enterobacter aerogenes1, Enterobacter cloacae1,Proteus vulgaris1, Staphylococcus aureus1, or Streptococcus agalactiae1</p><p>&nbsp;</p><p>q&nbsp; Complicated urinary tract infections due to Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, or Serratia marcescens1.</p><p>1Efficacy for this organism in this organ system was studied in fewer than 10 infections.</p><p>&nbsp;</p><p>&nbsp;</p><p>q&nbsp; Sexually transmitted diseases</p><p>Uncomplicated urethral and cervical gonorrhea due to Neisseria gonorrhoeae.</p><p>&nbsp;</p><p>q&nbsp; Prostatitis</p><p>Prostatitis due to Escherichia coli.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Route of administration: Oral</p><p>NORACIN tablets should be taken at least one hour before or at least two hours after a meal or ingestion of milk and/or other dairy products. Multivitamins, other products containing iron or zinc, antacids containing magnesium and aluminum, sucralfate, or didanosine, chewable/buffered tablets or the pediatric powder for oral solution, should not be taken within 2 hours of administration of norfloxacin.</p><p>NORACIN tablets should be taken with a glass of water. Patients receiving NORACIN should be well hydrated.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Normal renal function</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Infection</strong></p></td><td style="vertical-align:top"><p><strong>Dosage</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Therapy duration</strong></p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><em>Urinary Tract</em></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Uncomplicated UTI&#39;s (cystitis) due to E. coli,</p><p>K. pneumoniae, or P. mirabilis</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>400 mg every 12 hour</p></td><td colspan="2" style="vertical-align:top"><p>3 days</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Uncomplicated UTI&#39;s</p><p>due to other indicated organisms</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>400 mg every 12 hour</p></td><td colspan="2" style="vertical-align:top"><p>7-10 days</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Complicated UTI&#39;s</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>400 mg every 12 hour</p></td><td colspan="2" style="vertical-align:top"><p>10-21 days</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><em>Sexually Transmitted Diseases</em></p></td></tr><tr><td style="vertical-align:top"><p>Uncomplicated Gonorrhea</p><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>800 mg&nbsp; single</p><p>dose</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>1 day</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><em>Prostatitis</em></p></td></tr><tr><td style="vertical-align:top"><p>Acute or Chronic</p></td><td colspan="3" style="vertical-align:top"><p>400 mg every 12 hour</p></td><td style="vertical-align:top"><p>28 days</p></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Renal impairment</u></p><p>NORACIN may be used for the treatment of urinary tract infections in patients with renal insufficiency. In patients with a creatinine clearance rate of 30 mL/min/1.73 m2 or less, the recommended dosage is one 400-mg tablet once daily for the duration given above. At this dosage, the urinary concentration exceeds the MICs for most urinary pathogens susceptible to norfloxacin, even when the creatinine clearance is less than 10 mL/min/1.73 m2.</p><p>&nbsp;</p><p>When only the serum creatinine level is available, the following formula (based on sex, weight, and age of the patient) may be used to convert this value into creatinine clearance. The serum creatinine should represent a steady state of renal function.</p><p>&nbsp;</p><p>Elderly patients being treated for urinary tract infections who have a creatinine clearance of greater than 30 mL/min/1.73 m2 should receive the dosages recommended under normal renal function.</p><p>&nbsp;</p><p>Elderly patients being treated for urinary tract infections who have a creatinine clearance of 30 mL/min/1.73 m2 or less should receive 400 mg once daily as recommended under renal impairment.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Use in the elderly</u></p><p>Pharmacokinetic studies have shown no appreciable changes when compared to younger patients, apart from a slight prolongation of half-life. In the absence of renal impairment, no adjustment of dosage is necessary. Limited clinical studies have shown Norfloxacin to be well tolerated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Hypersensitivity to any component of this product or any chemically related quinolone antibacterials. 

	NORACIN is contra-indicated in prepubertal children and growing adolescents.

	NORACIN is contraindicated in patients with a history of tendinitis, or tendon rupture associated with the use of norfloxacin or any member of the quinolone group of antimicrobial agents.

	NORACIN should not be used in pregnancy and lactation (see section 4.6).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>q&nbsp; Central Nervous system effects: Fluoroquinolones, including NORACIN, have been associated with an increased risk of central nervous system (CNS) effects, including convulsion, increased intracranial pressure (including pseudotumor cerebri), and toxic psychoses Quinolones may also cause CNS stimulation wich may lead to tremors, restlessness lightheadedness, confusion, and hallucination. If these reactions occur in patients receving norfloxacin, the drug should should be discontinuted and appropriate measures institiuted.</p><p>The effect of norfloxacin on brain function or on the electrical activity of the brain have not been tested. Therefore until more information becomes available, norfloxacin, like all other other quionolones, should be used with caution in patients with known or suspected CNS disordes, such as severe cerebal arteriosclerosis, epilepsy, and other factors which predispose to seizures.</p><p>&nbsp;</p><p>q&nbsp; Tendinitis and/or tendon rupture, particularly affecting the Achilles tendon, may occur with quinolone antibiotics. Such reactions have been observed, particularly in older patients and in those treated concurrently with corticosteroids. At the first sign of pain or inflammation, patients should discontinue NORACIN and rest the affected limbs.</p><p>&nbsp;</p><p>q&nbsp; Photosensitivity reactions have been observed in patients who are exposed to excessive sunlight while receiving some members of this drug class. Excessive sunlight should be avoided. Therapy should be discontinued if photosensitivity occurs.</p><p>&nbsp;</p><p>q&nbsp; Quinolones, including Norfloxacin, may exacerbate the signs of myasthenia gravis and lead to life threatening weakness of the respiratory muscles. Caution should be exercised when using quinolones, including NORACIN, in patients with myasthenia gravis (see section 4.8 &#39;Undesirable effects&#39;).</p><p>&nbsp;</p><p>q&nbsp; Rarely, haemolytic reactions have been reported in patients with latent or actual defects in glucose-6-phosphate dehydrogenase activity who take quinolone antibacterial agents, including norfloxacin (see 4.8 &#39;Undesirable effects&#39;).</p><p>&nbsp;</p><p>q&nbsp; Very rarely, some quinolones have been associated with prolongation of the QTc interval on the electrocardiogram and infrequent cases of arrhythmia (including extremely rare cases of torsade de pointes) have been observed. As with other agents associated with prolongation of the QTc interval, caution should be exercised when using NORACIN in patients with hypokalaemia, significant bradycardia or undergoing concurrent treatment with class Ia or class III anti-arrhythmics.</p><p>&nbsp;</p><p>q&nbsp; &nbsp;Some quinolones including NORACIN should be used with caution in patients using cisapride, erythromycin, antipsychotics, tricyclic antidepressants or who have any personal or family history of QTc prolongation.</p><p>&nbsp;</p><p>q&nbsp; Pseudomembranous colitis has been reported with nearly all antibacterial agents, including NORACIN, and may range in severity from mild to life-threatening. Therefore it &#39;is important to consider this diagnosis in patients who present with diarrhoea subsequent to the administration of antibacterial agents. Studies indicate that a toxin produced by <em>Clostridium difficile</em> is a primary cause of &quot;antibiotic-associated colitis&quot;.</p><p>If CDAD is suspected or confirmed, ongoing antibiotic use not directed against <em>C.difficile</em> may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of <em>C.difficile</em>, and surgical evaluation should be instituted as clinically indicated.</p><p>&nbsp;</p><p>q&nbsp; Peripheral neuropathy (serious nerve damage) is an identified risk of fluoroquinolone drugs taken by mouth or by injection.</p><p>(Peripheral neuropathy symptoms in the arms or legs such as pain, burning, tingling, numbness, weakness or a change in sensation to light touch, pain or temperature).</p><p>&nbsp;</p><p>q&nbsp; Peripheral neuropathy can occur at any time during treatment with fluoroquinolone (may occur soon after these drugs are taken) and can last for months to years after the drug stopped or be permanent.</p><p>&nbsp;</p><p>q&nbsp; If a patient develops symptoms of peripheral neuropathy, the fluoroquinolone should be stopped and the patient should be switched to another non- fluoroquinolone antibacterial drug, unless the benefit of continued treatment with a fluoroquinolone outweghts the risk.</p><p>&nbsp;</p><p>q&nbsp; Endinopathy and Tendon Rupture: Fluoroquinolones, including NORACIN, are associated with an increased risk of tendinitis and tendon rupture in all ages. This adverse reaction most frequently involves the Achilles tendon, and rupture of the Achilles tendon may require surgical repair. Tendinitis and tendon rupture in the rotator cuff (the shoulder), the hand, the biceps, the thumb, and other tendon sites have also been reported. The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. Factors, in addition to age and corticosteroid use, that may independently increase the risk of tendon rupture include strenuous physical activity, renal failure, and previous tendon disorders such as rheumatoid arthritis. Tendinitis and tendon rupture have also occurred in patients taking fluoroquinolones who do not have the above risk factors. Tendon rupture can occur during or after completion of therapy; cases occurring up to several months after completion of therapy have been reported. Noracin should be discontinued if the patient experiences pain, swelling, inflammation or rupture of a tendon. Patients should be advised to rest at the first sign of tendinitis or tendon rupture, and to contact their healthcare provider regarding changing to a non-quinolone antimicrobial drug.</p><p>&nbsp;</p><p>q&nbsp; Clostridium Difficile Associated Diarrhea: Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Noracin and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.</p><p>C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.</p><p>If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.</p><p>&nbsp;</p><p>q&nbsp; Peripheral Neuropathy: Rare cases of sensory or sensorimotor axonal polyneuropathy affecting small and/or large axons resulting in paresthesias, hypoesthesias, dysesthesias and weakness have been reported in patients receiving quinolones, including norfloxacin. Norfloxacin should be discontinued if the patient experiences symptoms of neuropathy including pain, burning, tingling, numbness, and/or weakness, or is found to have deficits in light touch, pain, temperature, position sense, vibratory sensation, and/or motor strength in order to prevent the development of an irreversible condition.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Use in children</u></p><p>As with other quinolones, Norfloxacin has been shown to cause arthropathy in immature animals. The safety of Norfloxacin in children has not been adequately explored and therefore the use of Norfloxacin in prepubertal children or growing adolescents is contra-indicated</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Co-administration of probenecid does not affect serum concentrations of Norfloxacin, but urinary excretion of the drug diminishes.</p><p>As with other organic acid antibacterials, antagonism has been demonstrated in vitro between Norfloxacin and nitrofurantoin.</p><p>Quinolones, including Norfloxacin, have been shown in vitro to inhibit CYP1A2. Concomitant use with drugs metabolised by CYP1A2 (e.g. caffeine clozapine, ropinirole, theophylline, tizadine) may result in increased levels of these drugs, with the potential risk of increased toxicity. Patients taking any concomitant drugs metabolised by CYP1A2 should be carefully monitored.</p><p><u>Specifically in relation to this interaction: </u></p><p>Monitoring of theophylline plasma levels should be considered and dosage of theophylline adjusted as required.</p><p>The dose of clozapine or ropinirole may need to be adjusted in patients already taking these medications if Norfloxacin is introduced or withdrawn.</p><p>Co-administration of tizanidine and Norfloxacin is not recommended.</p><p>Elevated serum levels of ciclosporin have been reported with concomitant use of Norfloxacin. Ciclosporin serum levels should be monitored and appropriate ciclosporin dosage adjustments made when these drugs are used concomitantly.</p><p>Quinolones, including Norfloxacin, may enhance the effects of the anticoagulant warfarin, or its derivatives, by displacing significant amounts from serum albumin-binding sites. When concomitant administration of these products cannot be avoided, measurements of prothrombin time or other suitable coagulation tests should be carried out.</p><p>The concomitant administration of quinolones including Norfloxacin with glibenclamide (a sulphonylurea agent) has, on occasions, resulted in severe hypoglycaemia. Therefore monitoring of blood glucose is recommended when these agents are co-administered.</p><p>Multivitamins, products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within two hours of, the administration of Norfloxacin because they may interfere with absorption, resulting in lower serum and urine levels of Norfloxacin.</p><p>Products containing didanosine should not be administered concomitantly with, or within 2 hours of the administration of Norfloxacin, because the products may interfere with absorption resulting in lower serum and urine levels of Norfloxacin.</p><p>The concomitant administration of a non-steroidal anti-inflammatory drug (NSAID) with a quinolone including Norfloxacin, may increase the risk of CNS stimulation and convulsive seizures. Therefore NORACIN should be used with caution in individuals receiving NSAIDS concomitantly.</p><p>Animal data have shown that quinolones in combination with fenbufen can lead to convulsions. Therefore, concomitant administration of quinolones and fenbufen should be avoided.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1-1-1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use during pregnancy</p><p>Pregnant women and breast feeding mothers should not be prescribed 400 mg tablets as there are insufficient findings on safety of use in these groups of subjects and, on the basis of results from animal studies, damage to articular cartilage in the immature organism cannot completely be excluded. Norfloxacin passes into umbilical blood and amniotic fluid.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>1-1-2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use during lactation</p><p>It is generally known that quinolones pass into mother&rsquo;s milk. In case of treatment of breast feeding mothers with norfloxacin, breast feeding must be stopped</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Norfloxacin may cause dizziness and lightheadedness and, therefore, patients should know how they react to Norfloxacin before they drive or operate machinery or engage in activities requiring mental alertness and coordination.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The overall incidence of drug-related side effects reported during clinical trials was approximately 3%.</p><p>The most common side effects have been gastro-intestinal, neuropsychiatric and skin reactions, and include nausea, headache, dizziness, rash, heartburn, abdominal pain/cramps, and diarrhoea.</p><p>Less commonly, other side effects such as anorexia, sleep disturbances, depression, anxiety/nervousness, irritability, euphoria, disorientation, hallucination, tinnitus, and epiphora have been reported.</p><p>Abnormal laboratory side effects observed during clinical trials included:</p><p>Leucopenia, elevation of ALAT (SGPT), ASAT (SGOT), eosinophilia, neutropenia, thrombocytopenia.</p><p>With more widespread use the following additional side effects have been reported:</p><p><u>Hypersensitivity reactions</u></p><p>Hypersensitivity reactions including anaphylaxis, angioedema, dyspnoea, vasculitis, urticaria, arthritis, myalgia, arthralgia and interstitial nephritis.</p><p><u>Skin</u></p><p>Photosensitivity, Stevens Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis, erythema multiforme, pruritus, leukocytoclastic vasculitis</p><p><u>Gastro-intestinal</u></p><p>Pseudomembranous colitis, pancreatitis (rare), hepatitis, jaundice including cholestatic jaundice and elevated liver-function tests.</p><p><u>Musculoskeletal</u></p><p>Tendinitis, tendon rupture, exacerbation of myasthenia gravis, elevated creatinine kinase (CK).</p><p><u>Nervous system/psychiatric</u></p><p>Polyneuropathy including Guillaine-Barr&eacute; syndrome, confusion, paraesthesia, hypoaesthesia, psychic disturbances including psychotic reactions, convulsions, tremors, myoclonus.</p><p><u>Haematological</u></p><p>Agranulocytosis, haemolytic anaemia, sometimes associated with glucose-6-phosphate dehydrogenase deficiency.</p><p><u>Genito-urinary</u></p><p>Vaginal candidiasis.</p><p><u>Renal function</u></p><p>Renal failure.</p><p><u>Special senses</u></p><p>Dysgeusia, visual disturbances, hearing loss.</p><p><u>Cardiovascular</u></p><p>Very rarely: prolonged QTc interval and ventricular arrhythmia (including torsade de pointes) may occur with some quinolones including Norfloxacin.</p><p>To report any side effect (s):</p><p>&nbsp;Saudi Arabia: National Pharmacovigilance &amp; Drug Safety Centre (NPC)</p><p>q&nbsp; Fax: +966-11-205-7662</p><p>q&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>q&nbsp; Toll free phone: 8002490000</p><p>q&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>q&nbsp; Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No information is available at present.</p><p>In the event of recent acute overdosage, the stomach should be emptied by induced vomiting or by gastric lavage and the patient carefully observed and given symptomatic and supportive treatment. Adequate hydration must be maintained</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Fluoroquinolone</p><p>ATC code: JO1MA06</p><p><u>Mode of Action</u></p><p>Norfloxacin inhibits bacterial deoxyribonucleic acid synthesis and is bactericidal. At the molecular level, three specific events were attributed to Norfloxacin in <em>Escherichia coli </em>cells:</p><p>(1) Inhibition of the ATP-dependent DNA supercoiling reaction catalysed by DNA gyrase</p><p>(2) Inhibition of the relaxation of supercoiled DNA</p><p>(3) Promotion of double-stranded DNA breakage.</p><p>NORACIN has a broad spectrum of antibacterial activity against Gram-positive and Gram-negative aerobic pathogens. The fluorine atom at the 6 position provides increased potency against Gram-negative organisms and the piperazine moiety at the 7 position is responsible for the anti-pseudomonal activity.</p><p><u>PK/PD relationship</u></p><p>Efficacy is mainly dependent upon the C<sub>max</sub> (maximum serum concentration): MIC (minimum inhibitory concentration) ratio of the pathogen and the AUC (area under the curve): MIK ratio of the pathogen, respectively.</p><p><u>Mechanism/s of Resistance</u></p><p>The major mechanism of resistance to the quinolones, including Norfloxacin, is through mutations in the genes that encode for DNA gyrase and topoisomerase IV, the targets of quinolone action. Additional mechanisms of resistance include mutations in the cell membrane proteins, which alter membrane permeability and the development of efflux pumps.</p><p>There is no cross-resistance between Norfloxacin and structurally unrelated antibacterial agents such as penicillins, cephalosporins, tetracyclines, macrolides, aminocyclitols and sulphonamides, 2, 4 diaminopyrimidines, or combinations thereof (e.g. co-trimoxazole).</p><p><u>Break points </u></p><p>EUCAST clinical MIC breakpoints to separate susceptible (S) pathogens from resistant (R) pathogens are:</p><p><em>Entero-bacteriaceae</em> S&lt;0.5mcg/ml, R&gt;1mcg/ml</p><p>For <em>Neisseria gonorrhoeae</em> and other species MIC breakpoint not defined.</p><p><u>Susceptibility</u></p><p>The prevalence of resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. The information below gives only approximate guidance on the probability as to whether the micro-organism will be susceptible to Norfloxacin or not.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Commonly susceptible species:</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Gram-negative aerobes:</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Aeromonas hydrophilia</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Proteus vulgaris</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Providencia rettgeri</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Salmonella spp.</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Shigella spp.</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Species for which acquired resistance may be a problem:</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Gram-positive aerobes:</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus faecalis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus (including penicillinase-producing strains)</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus epidermidis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus saprophyticus</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus agalactiae</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Gram-negative aerobes:</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Citrobacter freundii</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterobacter aerogenes</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterobacter cloacae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Escherichia coli</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Klebsiella oxytoca</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Klebsiella pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Morganella morganii</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Proteus mirabilis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Providencia stuartii</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Pseudomonas aeruginosa</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Serratia marcescens</em></p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Norfloxacin is rapidly absorbed following oral administration. In healthy volunteers, at least 30-40% of an oral dose of Norfloxacin is absorbed. This results in a serum concentration of 1.5 mcg/ml being attained approximately 1 hour after administration of a 400 mg dose. Mean serum half-life is 3 to 4 hours, and is independent of dose.</p><p>The following are mean concentrations of Norfloxacin in various fluids and tissues measured 1 to 4 hours post-dose after the two 400 mg doses, unless otherwise indicated:.&nbsp;&nbsp;</p><p>Renal parenchyma&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;7.3 mcg/g</p><p>Prostate&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.5 mcg/g</p><p>Seminal fluid&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.7 mcg/ml</p><p>Testicle&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.6 mcg/g</p><p>Uterus/cervix&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.0 mcg/g</p><p>Vagina&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.3 mcg/g</p><p>Fallopian tube&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.9 mcg/g</p><p>Bile&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.9 mcg/ml (after 2 x 200 mg doses).</p><p>Norfloxacin is eliminated through metabolism, biliary excretion and renal excretion. After a single 400 mg dose of Norfloxacin, mean antimicrobial activities equivalent to 278, 773 and 82 mcg of Norfloxacin/g of faeces were obtained at 12, 24 and 48 hours, respectively.</p><p>Renal excretion occurs by both glomerular filtration and net tubular secretion, as evidenced by the high rate of renal clearance (approximately 275 ml/min). After a single 400 mg dose, urinary concentrations reach a value of 200 or more mcg/ml in healthy volunteers and remain above 30 mcg/ml for at least 12 hours. In the first 24 hours, 33-48% of the drug is recovered in the urine.</p><p>Norfloxacin exists in the urine as norfloxacin and six active metabolites of lesser antimicrobial potency. The parent compound accounts for over 70% of total excretion. The bactericidal potency of norfloxacin is not affected by the pH of urine.</p><p>Protein binding is less than 15%.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Norfloxacin, when administered to 3- to 5-month-old dogs at doses four or more times the usual human dose, produced blister formation and eventual erosion of the articular cartilage of the weight-bearing joints. Similar changes have been produced by other structurally related drugs. Dogs six months or older were not susceptible to these changes.</p><p>Teratology studies in mice and rats and fertility studies in mice at oral doses of 30 to 50 times the usual dose for humans did not reveal teratogenic or foetal toxic effects. Embryotoxicity was observed in rabbits at doses of 100 mg/kg/day. This was secondary to maternal toxicity and it is a non-specific antimicrobial effect in the rabbit due to an unusual sensitivity to antibiotic-induced changes in the gut microflora.</p><p>Although the drug was not teratogenic in cynomolgus monkeys at several times the therapeutic human dosage, an increased percentage of embryonic losses was observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>q&nbsp; Stearic Acid</p><p>q&nbsp; Sodium Starch Glycollate</p><p>q&nbsp; Microcrystalline Cellulose</p><p>q&nbsp; Povidone 29-32</p><p>q&nbsp; Sodium Lauryl Sulphate</p><p>q&nbsp; Colloidal Anhydrous Silica</p><p>Opadry OY-8413</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C, protected from light and humidity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NORACIN 400 Tablets are packed in boxes of 14 Tablets blistered in aluminium foil.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;No special requirements.</p><p>&nbsp;Any unused product or waste material should be disposed of in accordance with local requirements.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Jordanian Pharmaceutical Manufacturing Co. Ltd.
PO Box 151
Um Al-Amad 16197
Jordan

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                August 2018.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>